Diffuse posterior uveitis Withdrawn Phase 2 Trials for Piclidenoson (DB05511)

Also known as: Posterior Uveitis / Chorioretinitis / Uveitis, Posterior / Photoretinitis / Chorioretinitis NOS / Choriodoretinitis / Chorioretinitis, unspecified

IndicationStatusPhase
DBCOND0022016 (Diffuse posterior uveitis)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01905124Safety &Efficacy of CF101 to Subjects With UveitisTreatment